Genocea Biosciences, Inc.
GNCA
GNCA was delisted on the 2nd of June, 2022.
60 hedge funds and large institutions have $182M invested in Genocea Biosciences, Inc. in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 29 increasing their positions, 7 reducing their positions, and 6 closing their positions.
314% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 7
217% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 6
28% more funds holding
Funds holding: 47 → 60 (+13)
27% more capital invested
Capital invested by funds: $143M → $182M (+$39.2M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.93M |
| 2 |
Millennium Management
New York
|
+$2.87M |
| 3 |
TCP
Tourbillon Capital Partners
New York
|
+$2.26M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.07M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$3.25M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$2.01M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.74M |
| 4 |
PVMCV
Polaris Venture Management Co V
Boston,
Massachusetts
|
-$1.01M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$912K |
GNCA Hedge Fund Activity: Q2 2015 in Review
60 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Genocea Biosciences, Inc. (GNCA) for Q2 2015, worth a combined $182M — up 27% from $143M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new GNCA positions and 6 closed out — a net gain of 13 holders — while 29 added to existing stakes and 7 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $3.93M. The largest seller was Deerfield Management, cutting an estimated $3.25M.
- 60 institutional investors held Genocea Biosciences, Inc. (GNCA) as of Q2 2015, up from 47 in Q1 2015.
- Funds reported $182M of Genocea Biosciences, Inc. stock for Q2 2015, up 27% quarter-over-quarter.
- 19 funds opened new Genocea Biosciences, Inc. positions in Q2 2015 and 6 closed out, a net change of +13 holders.
- The largest Genocea Biosciences, Inc. buyer in Q2 2015 was BlackRock Fund Advisors, an estimated $3.93M added.
- The largest Genocea Biosciences, Inc. seller in Q2 2015 was Deerfield Management, an estimated $3.25M sold.
Based on aggregated 13F filings for Q2 2015.